Jakob Dupont Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jakob Dupont.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jakob Dupont. Jakob Dupont is SVP & Chief Medical Officer in OncoMed Pharmaceuticals Inc ($OMED) and EVP, Head of R&D in Atara Biotherapeutics, Inc. ($ATRA) and Chief Medical Officer in Gossamer Bio, Inc. ($GOSS).
Latest Insider Trading Transactions of Jakob Dupont
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRA, GOSS, OMED
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Option Exercise | A | 17.11 | 81,327 | 1,391,098 | 81,327 | |
| Mar 03 2021 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Grant | A | 0.00 | 53,879 | 0 | 100,129 | 46.3 K to 100.1 K (+116.50 %) |
| May 19 2020 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Option Exercise | A | 9.58 | 277,500 | 2,658,450 | 277,500 | |
| May 19 2020 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Grant | A | 0.00 | 46,250 | 0 | 46,250 | 0 to 46.3 K |
| Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | A | 14.55 | 71,500 | 1,040,325 | 71,500 | |
| Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Grant | A | 0.00 | 46,500 | 0 | 46,500 | 0 to 46.5 K |
| Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | M | 10.71 | 40,000 | 428,400 | 439,317 | |
| Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | M | 10.71 | 1,994 | 21,356 | 479,317 | |
| Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Sell | S | 15.00 | 40,000 | 600,004 | 0 | 40 K to 0 (-100.00 %) |
| Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Buy | M | 10.71 | 40,000 | 428,400 | 40,000 | 0 to 40 K |
| Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Sell | S | 15.81 | 1,994 | 31,534 | 0 | 2 K to 0 (-100.00 %) |
| Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Buy | M | 10.71 | 1,994 | 21,356 | 1,994 | 0 to 2 K |
| Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | A | 22.10 | 65,000 | 1,436,500 | 65,000 | |
| Oct 11 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Grant | A | 0.00 | 12,500 | 0 | 34,440 | 21.9 K to 34.4 K (+56.97 %) |
| Jan 12 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 2,500 | 11,400 | 138,937 | |
| Jan 12 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 20.01 | 2,500 | 50,021 | 20,642 | 23.1 K to 20.6 K (-10.80 %) |
| Jan 12 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 2,500 | 11,400 | 23,142 | 20.6 K to 23.1 K (+12.11 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 21.33 | 1 | 21 | 20,642 | 20.6 K to 20.6 K (0.00 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 21.54 | 69 | 1,486 | 20,643 | 20.7 K to 20.6 K (-0.33 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 22.30 | 2,092 | 46,653 | 20,712 | 22.8 K to 20.7 K (-9.17 %) |
| Dec 29 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | A | 21.43 | 70,000 | 1,500,100 | 70,000 | |
| Dec 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 2,500 | 11,400 | 141,437 | |
| Dec 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 20.49 | 2,500 | 51,231 | 22,804 | 25.3 K to 22.8 K (-9.88 %) |
| Dec 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 2,500 | 11,400 | 25,304 | 22.8 K to 25.3 K (+10.96 %) |
| Nov 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 2,500 | 11,400 | 143,937 | |
| Nov 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 21.17 | 2,500 | 52,923 | 22,804 | 25.3 K to 22.8 K (-9.88 %) |
| Nov 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 2,500 | 11,400 | 25,304 | 22.8 K to 25.3 K (+10.96 %) |
| Oct 27 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 5,000 | 22,800 | 146,437 | |
| Oct 27 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 20.00 | 5,000 | 100,000 | 22,804 | 27.8 K to 22.8 K (-17.98 %) |
| Oct 27 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 5,000 | 22,800 | 27,804 | 22.8 K to 27.8 K (+21.93 %) |
| Aug 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 2,500 | 11,400 | 151,437 | |
| Aug 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 22.25 | 2,500 | 55,622 | 22,377 | 24.9 K to 22.4 K (-10.05 %) |
| Aug 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 2,500 | 11,400 | 24,877 | 22.4 K to 24.9 K (+11.17 %) |
| Jul 13 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 2,500 | 11,400 | 153,937 | |
| Jul 13 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 20.13 | 2,500 | 50,325 | 22,377 | 24.9 K to 22.4 K (-10.05 %) |
| Jul 13 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 2,500 | 11,400 | 24,877 | 22.4 K to 24.9 K (+11.17 %) |
| Jul 07 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 2,500 | 11,400 | 156,437 | |
| Jul 07 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 21.22 | 2,500 | 53,050 | 22,377 | 24.9 K to 22.4 K (-10.05 %) |
| Jul 07 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 2,500 | 11,400 | 24,877 | 22.4 K to 24.9 K (+11.17 %) |
| Apr 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 158,937 | |
| Apr 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 26.51 | 1,500 | 39,765 | 22,377 | 23.9 K to 22.4 K (-6.28 %) |
| Apr 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 23,877 | 22.4 K to 23.9 K (+6.70 %) |
| Mar 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 160,437 | |
| Mar 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 27.17 | 1,500 | 40,754 | 21,620 | 23.1 K to 21.6 K (-6.49 %) |
| Mar 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 23,120 | 21.6 K to 23.1 K (+6.94 %) |
| Feb 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 161,937 | |
| Feb 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 24.23 | 1,500 | 36,351 | 21,620 | 23.1 K to 21.6 K (-6.49 %) |
| Feb 12 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 23,120 | 21.6 K to 23.1 K (+6.94 %) |
| Jan 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 163,437 | |
| Jan 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 26.62 | 400 | 10,648 | 21,620 | 22 K to 21.6 K (-1.82 %) |
| Jan 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 25.63 | 1,100 | 28,188 | 22,020 | 23.1 K to 22 K (-4.76 %) |
| Jan 14 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 23,120 | 21.6 K to 23.1 K (+6.94 %) |
| Jan 07 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 7,500 | 34,200 | 164,937 | |
| Jan 07 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 23.00 | 7,500 | 172,500 | 21,620 | 29.1 K to 21.6 K (-25.76 %) |
| Jan 07 2015 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 7,500 | 34,200 | 29,120 | 21.6 K to 29.1 K (+34.69 %) |
| Dec 22 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | A | 21.18 | 50,000 | 1,059,000 | 50,000 | |
| Jul 25 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 172,437 | |
| Jul 25 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 23.00 | 1,500 | 34,500 | 20,896 | 22.4 K to 20.9 K (-6.70 %) |
| Jul 25 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 22,396 | 20.9 K to 22.4 K (+7.18 %) |
| Jun 30 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 173,937 | |
| Jun 30 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 23.00 | 1,500 | 34,503 | 20,896 | 22.4 K to 20.9 K (-6.70 %) |
| Jun 30 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 22,396 | 20.9 K to 22.4 K (+7.18 %) |
| Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Grant | A | 0.00 | 20,000 | 0 | 20,896 | 896 to 20.9 K (+2,232.14 %) |
| Jul 19 2013 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | A | 17.00 | 45,000 | 765,000 | 45,000 |
Page: 1